Bullfrog AI Holdings Inc(BFRG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.48 | Insider Own | 12.87% | Shs Outstand | 18.5M | Perf Week | -6.99% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 16.2M | Perf Month | -21.1% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -0.09 | Inst Own | 6.36% | Short Float | 0.58% | Perf Quarter | -29.81% |
| Income | -0.01B | P/S | 27.72 | EPS this Y | - | Inst Trans | 11.69% | Short Ratio | 0.68 | Perf Half Y | -27.79% |
| Sales | 0.00B | P/B | 1.19 | EPS next 5Y | - | ROA | -113.54% | Short Interest | 0.09M | Perf YTD | -49.22% |
| Book/sh | 0.38 | P/C | 1.2 | EPS past 3/5Y | -10.94% -59.71% | ROE | -130.71% | 52W High | -78.02% ($2.04) | Perf Year | -68.09% |
| Cash/sh | 0.37 | P/FCF | - | Sales past 3/5Y | 126.81% - | ROIC | -85.82% | 52W Low | 5.46% ($0.43) | Perf 3Y | -84.59% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 38.11% | Gross Margin | 40.34% | Volatility(W/M) | 6.68% 7% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 4.95 | Sales Y/Y TTM | 798.45% | Oper. Margin | -2042.19% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 10.57 | EPS Q/Q | 51.17% | Profit Margin | -2006.87% | RSI (14) | 30.46 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.57 | Sales Q/Q | 547.64% | SMA20 | -13.91% ($0.52) | Beta | -2.63 | Target Price | - |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/09/02 | SMA50 | -22.68% ($0.58) | Rel Volume | 0.63 | Prev Close | $0.47 |
| Employees | 9 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -37.65% ($0.72) | Avg Volume(3M) | 0.14M | Price | $0.45 |
| IPO | 2023/2/14 | Option/Short | No/Yes | Trades | 151 | Volume | 87,128 | Change | -4.86% |
Company
BFRG is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
This company holds an exclusive license to technology from the Johns Hopkins University Applied Physics Laboratory (APL) and operates an AI platform designed for drug discovery and precision medicine, identifying novel drug targets and patient subgroups from biomedical data. Its end-to-end AI pipeline consists of three core platforms: bfLEAP®, the primary discovery engine; bfPREP™, a data preprocessing tool; and bfARENAS™, which supports clinical trial design. Through this integrated workflow, the company provides technology services to global pharmaceutical and biotech firms.
Over the past 1 year, on the lower side
78% below its 1-year high.
BFRG has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Generally in line with estimates
Tap to view numbers
Holding long would have lost money
Would have changed by -84.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 6.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DFSU 0.00%
VTI 0.00%
VXF 0.00%It ranks #4 in the industry
Based on market cap of $8M.
BFRG $8M PER -
VEEV $43B PER 43.9
TEM $12B PER -
BTSG $12B PER 44.0
FAQ
What kind of company is BFRG?
BFRG belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of BFRG?
The market cap of BFRG is approximately $8M, ranking 5,549 within its sector.
What is the 52-week high and low for BFRG?
BFRG has recorded a 52-week high of $2.04 and a low of $0.43.
